Pillstats
Rx only · Capsule, Extended Release · Oral

Potassium Chloride

Potassium Chloride

18 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US26 NDCs
18 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCA12BA01
RxCUI (US)8591
US makers19 labelers
Packages58
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 23 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.038$0.077$0.115$0.154Dec 2025Mar 2026Jul 2026
$0.124
Latest avg · Jul 22, 2026
+0%
Since Dec 17, 2025
18
Active US suppliers
27%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

26K51K77K103K2025 Q12025 Q22025 Q32025 Q42026 Q1
76K
Rx · 2026 Q1
4.4M
Units dispensed
-11%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it18 active · 1 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Zydus Pharmaceuticals USA Inc.unknown8SUPPLYING
Granules India Limitedunknown7SUPPLYING
PD-Rx Pharmaceuticals, Inc.unknown5SUPPLYING
BluePoint Laboratoriesunknown4SUPPLYING
Bryant Ranch Prepackrepackager3SUPPLYING
SUN PHARMACEUTICAL INDUSTRIES, INC.unknown3SUPPLYING
Granules Pharmaceuticals Incunknown3SUPPLYING
Amneal Pharmaceuticals of New York LLCunknown3SUPPLYING
Solco Healthcare US, LLCunknown3SUPPLYING
Glenmark Pharmaceuticals Inc., USAunknown3SUPPLYING
NorthStar Rx LLCunknown2SUPPLYING
REMEDYREPACK INC.repackager2SUPPLYING
A-S Medication Solutionsunknown2SUPPLYING
NCS HealthCare of KY, LLC dba Vangard Labsunknown2SUPPLYING
American Health Packagingunknown2SUPPLYING

+ 4 more labelers

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jun 25, 2024
    RECALLRecall (Class I): Potassium Chloride Extended-Release Capsules, USP, (750 mg) 10 mEq K, a).100-count bottle ( NDC 68001-396-00), b) 500-c…

    Failed Dissolution Specifications — Recalling firm: Amerisource Health Services LLC — US Nationwide.

  • May 30, 2024
    RECALLRecall (Class I): Potassium Chloride Extended-Release Capsules, USP, (750 mg) 10 mEq K, 100-count bottle, Rx Only, Manufactured by: Glenm…

    Failed Dissolution Specifications — Recalling firm: Glenmark Pharmaceuticals Inc., USA — Nationwide

  • May 30, 2024
    RECALLRecall (Class II): Potassium Chloride Extended-Release Capsules, USP, (750 mg) 10 mEq K, 500-count bottle, Rx Only, Manufactured by: Glenm…

    CGMP Deviations — Recalling firm: Glenmark Pharmaceuticals Inc., USA — Nationwide

  • May 30, 2024
    RECALLRecall (Class I): Potassium Chloride Extended-Release Capsules, USP, (750 mg) 10 mEq K, 500-count bottle, Rx Only, Manufactured by: Glenm…

    Failed Dissolution Specifications — Recalling firm: Glenmark Pharmaceuticals Inc., USA — Nationwide

  • May 30, 2024
    RECALLRecall (Class II): Potassium Chloride Extended-Release Capsules, USP, (750 mg) 10 mEq K, 100-count bottle, Rx Only, Manufactured by: Glenm…

    CGMP Deviations — Recalling firm: Glenmark Pharmaceuticals Inc., USA — Nationwide